| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |